![B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-020-00092-2/MediaObjects/41573_2020_92_Fig1_HTML.png)
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
![Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram](https://www.researchgate.net/publication/5788240/figure/fig1/AS:264519654047747@1440077808928/Anti-CD20-therapy-and-B-cells-in-autoimmunity-Autoreactive-B-cells-play-a-role-in.png)
Anti-CD20 therapy and B cells in autoimmunity. Autoreactive B cells... | Download Scientific Diagram
![B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram](https://www.researchgate.net/publication/313232213/figure/fig2/AS:457339691114499@1486049687549/B-cell-lineage-and-surface-marker-expression-A-diagram-of-a-simplified-development-and.png)
B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram
![Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model](https://www.frontiersin.org/files/MyHome%20Article%20Library/478945/478945_Thumb_400.jpg)
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
![Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab](https://pub.mdpi-res.com/brainsci/brainsci-10-00758/article_deploy/html/images/brainsci-10-00758-g001.png?1603195306)
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
![CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-00007-0/MediaObjects/41598_2021_7_Fig1_HTML.png)